Corpay vs WEX
CPAY and WEX side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CPAY and WEX compare
Corpay is the larger company, worth 4.2 times as much as WEX ($26.3B against $6.3B).
On earnings, WEX is cheaper: it trades at 15.9× trailing earnings, against 24.4× for Corpay.
Corpay grew revenue faster over the last twelve months (20.4% versus 9.7% for WEX).
Corpay keeps more of each dollar of sales as profit, with a net margin of 22.7% compared with 14.0% at WEX.
WEX scores higher on the StockData Score (14 against 11 for Corpay), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CPAY | WEX |
|---|---|---|
| Size and price | ||
| Market cap | $26.3B | $6.3B |
| Share price | $400.94 | $184.61 |
| Change, 1 year | 49.5% | 19.8% |
| Change, 5 years | 63.8% | 18.4% |
| Beta (5Y) | 1.17 | 1.03 |
| Employees | 12K | 6,600 |
| StockData Score | ||
| Total score | 11 | 14 (better) |
| Valuation score | 2 | 5 (better) |
| Growth score | 2 | 4 (better) |
| Performance score | 5 (better) | 4 |
| Health score | 2 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 24.4× | 15.9× (better) |
| P/S | 5.2× | 2.2× (better) |
| P/B | 7.4× | 5.5× (better) |
| EV/EBITDA | 10.5× | 6.2× (better) |
| P/FCF | 16.1× | – |
| PEG | 3.71 | 0.68 (better) |
| FCF yield | 6.2% (better) | −5.0% |
| Fair value | $405.01 | $307.71 |
| Margin of safety | 1.0% | 40.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 20.4% (better) | 9.7% |
| Revenue growth, 5Y average | 13.6% (better) | 11.3% |
| Net income growth (TTM) | 8.7% | 42.6% (better) |
| EPS growth (TTM) | 11.8% | 51.3% (better) |
| EPS growth, 5Y average | 13.1% | – |
| Profitability | ||
| Gross margin | – | 60.4% |
| Operating margin | 43.7% (better) | 26.6% |
| Net margin | 22.7% (better) | 14.0% |
| FCF margin | 32.6% (better) | −10.8% |
| Return on equity | 30.5% | 35.6% (better) |
| Return on invested capital | 34.0% | 46.4% (better) |
| Financial health | ||
| Debt / equity | 1.28 (better) | 4.62 |
| Net debt / EBITDA | 0.52 | 0.05 (better) |
| Interest coverage | 5.0× | – |
| Current ratio | 0.97 | 1.03 (better) |
| Altman Z-score | 1.59 (better) | 0.84 |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Buyback yield | 6.5% (better) | 4.2% |
| Shareholder yield | 6.5% (better) | 4.2% |
| Ownership | ||
| Held by institutions | 97.8% | 116% |
| Held by insiders | 5.3% | 6.4% |
| Insider net buying, 12 months | −$146M | −$10.1M (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 5.6% | 8.7% |
Go deeper
- CPAY stock overview
- CPAY income statement
- CPAY valuation and score
- WEX stock overview
- WEX income statement
- WEX valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.